Ami Patel: An honor to work with Naveen Pemmaraju on MPN review article
Ami Patel, Hematologist at Huntsman Cancer Institute, shared a post by Naveen Pemmaraju on X, adding:
“An honor to work with Naveen Pemmaraju on this!”
Quoting Naveen Pemmaraju’s post:
Super excited for our brand new Myelo-Proliferative Neoplasm (MPN) review article just out led by Ami Patel and Naveen Pemmaraju, Polycythemia vera: past, present and future: Leukemia and Lymphoma.”
Additional information
Source: Ami Patel/X and Naveen Pemmaraju/X
Naveen Pemmaraju is a Professor and Director of the BPDCN Program at the Department of Leukemia at the University of Texas MD Anderson Cancer Center (MDACC) and Executive Director of the MDACC Network. He is also the Leukemia Hematology/Oncology Course Director.
His research work has been focused on improving outcomes and developing novel therapies for patients with rare, and ultra-rare, myeloid malignancies; including adolescents, young adults, and older adult patients with Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN), MPN and AML.